Editorial commentary: rifampicin plus colistin in the era of extensively drug-resistant Acinetobacter baumannii infections
- PMID: 23616496
- DOI: 10.1093/cid/cit262
Editorial commentary: rifampicin plus colistin in the era of extensively drug-resistant Acinetobacter baumannii infections
Keywords: Acinetobacter baumannii; antimicrobial resistance; colistin; rifampicin.
Comment on
-
Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.Clin Infect Dis. 2013 Aug;57(3):349-58. doi: 10.1093/cid/cit253. Epub 2013 Apr 24. Clin Infect Dis. 2013. PMID: 23616495 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
